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Abstract 
Background The Physiological and Operative Severity Score for the enUmeration of Mortality 
andmorbidity (POSSUM) and later modifications (P-POSSUM y CRPOSSUM) have been used to 
predictmorbidity and mortality rates among patients with rectal cancer undergoing surgery. These 
calculations needsome adjustment, however. The aim of this study was to assess the applicability of 
POSSUM to a group ofpatients with rectal cancer undergoing surgery, analysing surgical morbidity 
by means of several variables. 
Methods between January 1995 and December 2004, 273 consecutive patients underwent surgery 
forrectal cancer. Information was gathered about the patients, tumour and therapy. To assess the 
predictioncapacity of POSSUM, subgroups for analysis were created according to variables related to 
operativemorbidity and mortality. 
Results The global morbidity rate was 23.6% (31.2% predicted by POSSUM). The mortality rate was 
0.7% (6.64, 1.95 and 2.08 predicted by POSSUM, P-POSSUM and CR-POSSUM respectively). 
POSSUMpredictions may be more accurate for patients younger than 51 years, older than 70 years, 
with low anaesthetic risk (ASA I/II), DUKES stage C and D, surgery duration of less than 180 minutes 
and for thosereceiving neoadjuvant therapy. 
Conclusion POSSUM is a good instrument to make results between different institutions and 
publicationcomparable. We found prediction errors for some variables related to morbidity. 
Modifications of surgicalvariables and specifications for neoadjuvant therapy as well as physiological 
variables including life stylemay improve future prediction of surgical risk. More research is needed to 
identify further potential riskfactors for surgical complications. 
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Introduction 
Surgical evaluation processes are well-known medical procedures that help us detect and correct 
errors, as well as reinforce correct decisions taken about surgery. Surgical scoring systems must be 
capable of predicting morbidity and mortality and be fast, user friendly and applicable to a wide 
spectrum of situations. The Physiological and Operative Severity Score for the enUmeration of 
Mortality and morbidity (POSSUM) scoring system has been used to assess the quality of surgical 
results so as to estimate the probability of morbidity and mortality of patients according to their 
preoperative physiological status and the magnitude of surgery. Thus the POSSUM scoring system 
offers a way of comparing the results of surgical procedures presenting different degrees of 
complexity [1, 2]. 
The main value of this scoring system is the scientific method used for its development [3–5], 
together with its simplicity. Different validation studies carried out [6, 7] have found mortality 
overprediction, especially among patients with low surgical risk. In 1998, a new equation known as 
P-POSSUM was therefore created to more accurately predict surgical mortality. 
This new system applies linear instead of exponential equations and uses different constants and 
values for the same Physiological and Operative Scores. Both POSSUM and P-POSSUM scores 
have proved to be reliable mortality predictors for patients undergoing general and special surgery 
[1, 4, 5, 8]. When applied specifically to colorectal surgery, these scoring systems have been found 
to overpredict mortality in elective surgical procedures and to underpredict mortality in elderly 
patients and in cases of emergency surgery [9–12]. This fact led to the development, in 2004, of the 
CR-POSSUM, which is specific for colorectal surgery [13]. It seems to be the most accurate scoring 
system, compared with the previous ones [14–16]. 
Our aim was to evaluate the quality of care at our centre, assessing morbidity and mortality over 
several years. Therefore, we applied the three described scoring systems to a group of patients 
consecutively diagnosed with rectal adenocarcinoma and treated with long term preoperative 
chemoradiotherapy and surgery. Furthermore, we wanted to determine the relationship with other 
factors that may predict complications. 
 
Patients and methods 
Between January 1995 and December 2004, 273 patients diagnosed with rectal adenocarcinoma 
(tumour margin within 16 cm from the anal verge) were treated in our hospital. A multidisciplinary 
team made up of oncologists, radiotherapists and surgeons with a special interest in colorectal 
pathology attended them. A database was created with prospective information collected about the 
patients (age, gender, BMI and ASA) [17], the surgical procedures (type and duration of surgery, 
ileostomy, type of anastomosis and blood transfusion), the radiotherapy (dose, duration and interval 
between radiotherapy and surgery), and about the tumour (tumor, node, metastasis [TNM] staging 
[18] and location). 
Patients were assigned to two different groups: group A was made up of 170 patients, who were 
given both chemoradiotherapy and surgery, and group B was made up of 103 patients treated with 
surgery alone. Chemoradiotherapy was prescribed for all patients whose preoperative staging 
revealed tumour infiltration deeper than the muscular layer (T3) or lymph nodes suspicious of 
metastasis (N+). All patients not fulfilling these criteria (71/ 103) as well as those with metastasis 
(M1) (24/103) were included in group B to avoid delay in systemic chemotherapy. Finally, patients 
who refused preoperative chemoradiotherapy were also assigned to group B (8/103). 
 
Preoperative radiotherapy 
External radiotherapy was applied in two, three and four fields according to the guidelines given 
in the 50th Report of the International Commission on Radiation Units and Measurements [19], 
including the primary tumour and regional, mesorectal, presacral and internal iliac (up to L5 S1) 
lymph nodes. Most of the patients (77/103) received a standard dose of between 45 and 50.4 Gy in 
25 fractions over 5 weeks, associated with chemotherapy based on 5 fluorouracil (FU) boluses 
during the first and last week of radiotherapy. Fifteen patients received a reduced dose due to 
treatment intolerance and eleven received a dose over 50.4 Gy. All of them underwent surgery 
between the fourth and sixth week after completing radiotherapy. 
Surgical procedures 
All the patients underwent intestinal preparation the day before surgery, as well as intestinal 
decontamination with oral antibiotic therapy, antithrombotic prophylaxis, gastric protection and 
intravenous antibiotic prophylaxis against anaerobes and gram negative bacteria. The procedures 
employed were as follows: anterior rectal resection with stapled anastomosis, abdominoperineal 
resection and Hartmann’s procedure. A protective ileostomy was created according to the surgeon’s 
decision, taking into account technical factors, the general health of the patient and the use of 
neoadjuvant therapy with chemoradiotherapy. In all cases, information was gathered prospectively 
about the duration of the surgical procedure, blood loss and intra-operative blood transfusion 
requirements as decided by the anaesthetists. 
Statistical analysis 
Data collection was carried out using a computer database, and was supervised by the same 
surgeon throughout the whole study. The physiological and surgery parameters of the POSSUM 
score previous to the year 2000 were obtained from such a database, while more recent parameters 
were obtained prospectively. Data analysis was performed with the SPSS 11.0 program (SPSS, Inc, 
Chicago, IL, USA). Categorical variables were analysed using contingency tables and Chi-squared 
or Fisher exact probability, depending on the cases. Continuous variables were analysed with the 
Student t test. The association between independent variables and complications was analysed with 
a regression model. In same cases, variables were divided into categories and cutoff points for 
better analysis. Results between observed and predicted values (o/p index) were analysed according 
to this classification: 1.0±0.1: very good prediction; 1.0±0.25: good prediction. P values below 0.05 
were considered to be statistically significant. 
 
Results 
Series analysis 
The demographic characteristics of the 273 patients are shown in Table 1. The two groups are 
homogeneous for age, gender, BMI, ASA, type of surgery, need for blood transfusion, duration of 
surgery and hospital stay. 
Significant differences in tumour location and tumour stage between groups results from the type 
of therapeutic procedure, the main reason for the selection treatment (p= 0.002). Most of the patients 
allocated to preoperative radiotherapy (group A) received a standard dose of 45 to 50.4 Gy, with 
conventional fractioning (1.8 Gy), during a 5 week period. The mean dose was 4700 cGy (range 
3,696– 6,500 cGy). Chemotherapy with 5-FU (350 mg/m2/day) was given in the first and last week 
of the radiation period. The mean time between preoperative chemoradiotherapy and surgery was 38 
days (range 30–61 days). The mean radiotherapy duration was 36 days (range 20–70). 
The characteristics of the surgical procedures in both groups, with values of statistical 
significance, are also displayed in Table 1. Thirty-five per cent of patients were admitted to the ICU 
after surgery according to criteria of the anaesthetists and depending on the behaviour of the patient 
in theatres. The mean time of surgery in group A was 170 min (range 70–540) and was 150 min 
(range 45– 330) in group B, and there were no statistically significant differences. No statistically 
significant differences between the groups were found with regard to sphincter-preserving surgery 
(76.5% in group A vs 75.5% in group B) or blood transfusion (16.6% in group A vs 18.1% in group 
B). In group A, 38.3% of the patients underwent ileostomy vs 8.6% in group B (p<0.001). Other 
surgical procedures (cholecystectomy, hysterectomy, and hernia surgery) were combined with the 
tumour excision in 13% of the patients in group A vs 22.3% in group B (p=0.045). 
 
Complications 
The complications found in both groups are displayed in Table 2. It is important to note that, 
although statistically significant differences were not found between both groups, the number of 
patients suffering from complications was smaller in group A (23%) than in group B (32%) 
probably due to the more advanced tumour stage in group B (Table 1). 
Global mortality in the series (30 days mortality) was found only in two patients (0.7%): one in 
each group. The patient (0.6%) in the group treated with radiotherapy died of severe myocardial 
ischemia during the early postoperative period and the patient (1%) in the group treated with 
surgery alone died of intra-abdominal haemorrhage. 
The overall morbidity in our sample was 26.4% while that predicted by POSSUM was 31.2% 
(index observed/ predicted=0.84; Table 3). When analysing according to therapy groups, we found 
very good prediction for patients treated with surgery alone (group B) (O/P index=1.09), while for 
patients receiving neoadjuvant therapy (group A), POSSUM overpredicted the morbidity rate (O/P 
index= 0.71) (Table 4). 
The results obtained for the surgical mortality rate and a comparison of them are displayed in 
Table 5. Mortality prediction for POSSUM, P-POSSUM and CR-POSSUM was 6.64, 1.95 and 
2.08, respectively. The three scoring systems overpredicted mortality risk, although the PPOSSUM 
and CR-POSSUM showed higher accuracy. We should not forget that no cases of emergency 
surgery were included in this study. 
POSSUM was applied to subgroups according to variables classically associated with surgical 
morbidity and mortality (age, ASA, type of surgical procedure, duration of surgery and Dukes 
staging). The results are shown in Table 6. When applied to different age groups, it accurately 
predicted the morbidity rate for middle-aged groups (51–60 and 61–70 years old). However, over-
prediction for the other groups (<51 and >70 years old) was found. The sample was segmented by 
anaesthetic risk (ASA I/II and ASA III/IV) and duration of surgery (<180 min and >180 min). We 
obtained an appropriate POSSUM prediction for those patients with ASA I/II (O/P index=0.99) and 
an overprediction for patients with ASA III/IV (O/P index=0.75). Concerning the duration of 
surgery, the prediction was appropriate for surgical procedures lasting more than 3 h (O/P 
index=1.03), and morbidity was overpredicted in patients with a shorter duration of surgery (O/P 
index=0.68). Looking at the type of surgical procedure, we found an overprediction of the surgical 
complication rate for anterior rectal resection (O/P index=0.76) and for Hartmann’s procedure (O/P 
index= 0.85), as well as an underprediction for abdomino-perineal resection (O/P index=1.15). 
Analysis by Dukes staging showed an appropriate prediction for patients with good prognosis; 
Dukes A and B (O/P index=1.04 and 0.98) and incorrect prediction for Dukes C and D (O/P 
index=0.73 and 1.29). 
Finally, morbidity rates observed and expected through application of the POSSUM equation were 
compared for the different risk groups in our sample. For those groups with higher expected rates, 
the number of patients with complications observed was also higher. Analysing this fact we found a 
correct correlation between the proportion of patients with complications and the proportion of 
expected cases by POSSUM (Table 7). 
Discussion 
Surgical results are classically measured in terms of morbidity and mortality rates and hospital 
stay [3]. However, it may be misleading to establish comparisons based only on these variables. We 
should take into account that not all cases present the same degree of complexity and that reference 
hospitals usually have a concentration of the most complex ones, therefore registering higher rates 
of morbidity and mortality, and hospital stay [20]. This issue has been widely described in the 
literature [3, 21–23] and that is why several scoring systems for prediction and quality care control 
have been developed over the years. The only way to objectively compare surgical teams, hospitals 
and surgeons is by estimating morbidity and mortality rates adjusted according to the risk of each 
patient or group of patients [3]. 
In our study, we wanted to assess all these aspects, so as to fully comprehend our situation and to 
be able to analyse it as a part of the health system. 
The principal investigator was present during the data collection process and supervised data input 
in the different models and scoring systems. Physiological and Operative Severity Scores were 
similar to series previously analysed, allowing us to compare them with the results of other 
institutions (Table 8). The mean Physiological and Operative Severity Scores were 16.07 (range 12–
35) and 13.03 (range 8–30), respectively. Predicted mean morbidity was 31.2% and predicted mean 
mortality was 6.64% with the POSSUM score. Observed morbidity was 26.4% and observed 
mortality was 0.7%. The number of emergency surgical procedures in our study was zero since the 
few patients who presented as emergencies were stabilized and later referred for elective surgery. 
This decrease in morbidity and mortality rates among emergency patients treated electively was 
described by Tekkis et al. where mortality rates were reduced from 20 to 12.9% in patients treated 
for obstructive colorectal cancer [13]. 
It is well-known that POSSUM and P-POSSUM overpredict general mortality and morbidity, 
and that the creation of subgroups is needed to more accurately estimate risk values [9–12]. CR-
POSSUM is a specific scoring system for colorectal cancer and is more reliable but still needs 
further adjustment [15, 16]. In an attempt to improve the validity of POSSUM, we analysed the 
effect it has over different variables classically associated with surgical morbidity. 
The classification of the American Society of Anesthesiology (ASA) has been used since 1961 to 
easily quantify surgical morbidity and mortality risk [24]. It has proven to be an accurate predictor 
of surgical risk, with an added predictive value when taking into account the age of the patients 
[25]. ASA staging, being a simple method, is partially open to subjective interpretation by the 
specialists and that is why it has been incorporated in other predictive indexes. In our analysis, we 
found an overprediction of the surgical morbidity rates for those patients with low anaesthetic risk 
(ASA I/II; 20.6% vs 27.3%) and a precise prediction for those with high anaesthetic risk (ASA 
III/IV; 40.5% vs 40.9%). In line with this, we also found an overprediction of the morbidity risk for 
the extreme age groups (<51 and >70 years old), and an accurate prediction for those age groups 
where colorectal cancer is more common (51–60 and 61–70 years old). Similar to other published 
studies [26–28], we did not find a higher incidence of complications among elderly patients. There-
fore, we consider that similar surgical procedures can be done without increasing the number of 
complications. 
Traditionally, radiotherapy has been associated with higher postoperative morbidity and mortality 
rates, principally due to a higher incidence of anastomotic leak. However, evidence for this is 
derived only from scientific experiments [29, 30]. According to our experience and that of other 
studies [31–35], the morbidity rates are not increased in patients treated with neoadjuvant therapy 
(group A), compared to those patients treated with surgery alone (group B) (22.9% vs 26.4%). 
When applying POSSUM to the groups created with this variable, we observed an overprediction 
of morbidity rates in patients receiving neoadjuvant therapy (group A) (22.9% vs 32.05%) and an 
accurate prediction in patients treated with surgery alone (group B) (32% vs 29.1%). This disparity 
could be explained by the absence of this variable (neoadjuvant therapy) among the physiological 
and operative parameters considered in POSSUM. We believe it is important to incorporate this 
variable in future predictive models. 
The POSSUM scoring system includes in the Operative Severity Score the type of surgical 
procedure and the degree of tumour malignancy, classified from less to more (minor, intermediate, 
major and major+) and into lack of malignancy, primary neoplasia, lymph node metastasis and 
distant metastasis. Most of the surgical procedures were classified as major procedures. However, we 
analysed them according to the type of surgical procedure (anterior rectal resection, 
abdominoperineal resection and Hartmann’s procedure) and the duration of surgery (<180 min and 
>180 min), noting an overprediction of the risk of complications for the anterior rectal resection and 
for Hartmann’s procedure as well as an underprediction for the abdominoperineal resection. 
Similarly, when surgical time measured from the first incision up to the closure of the laparotomy 
was longer than 3 h, POSSUM correctly predicted the operative morbidity rate. It was, however, 
overpredicted for shorter surgical procedures. It is well known that abdominoperineal resection 
carries a higher incidence of operative complications, compared to anterior rectal resection [36, 37]. 
In our experience, we found a higher rate of wound infection and of abdominal abscess among 
patients undergoing rectal amputation, especially due to delayed perineal wound healing (5.0% vs 
19.6%; p= 0.02) and (2.5% vs 8.9%; p=0.03). From these results, we consider it useful to define the 
domain “type of surgery” according to type of surgical procedure. Our results show a good 
correlation for low stages (Dukes A and B) and an underprediction for those cases with worse 
prognosis (Dukes C and D). The original POSSUM, as we saw above, categorises the domain 
“malignancy stage” according to the degree of malignancy; later modifications (CRPOSSUM) 
incorporate Dukes classification in the domain, probably correcting this potential error. 
Finally, in an attempt to assess the internal consistency of POSSUM scoring system and guided 
by the work of Ramkumar [15], we validated the precision of POSSUM, using stratified risk 
intervals (Table 7). We have seen that when the expected proportion of complications in POS SUM 
increases, the number of patients with complications in our study increased also. 
In conclusion, according to our experience, we think that the profit of these scores is to make 
results between institutions and publication comparable. POSSUM score should not be the only 
instrument to decide the best surgical option for patients according to our investigated results. The 
POSSUM scoring system and its later modifications (P-POSSUM and CR-POSSUM) overpredict 
the risk of operative mortality. In spite of that, POSSUM has permitted an important advance in the 
evaluation of colorectal cancer surgery, correctly estimating the probability of surgical morbidity in 
most cases. The described predictive models could also be used as a further step in the patient’s 
preoperative informed consent. It could also be used to compare the clinical practice among several 
institutions and to detect and correct errors. So far, a precise scoring system for colorectal surgery 
has not been developed. However, successive modifications will bring it closer to reality. We 
consider that modifications in operative parameters according to the type of surgical procedure and 
specifications for neoadjuvant therapy, as well as modifications in physiological parameters 
including life style habits, could improve prediction of surgical risk in future. Further studies on 
these lines are needed to more accurately identify potential risk factors for surgical complications. 
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Table 1 Patient demographics 
 
Group A Percent Group B Percent Total Percent p 
Age 
170  103  273   
 <51 37 21.7 13 12.6 50 18.3 0.274 
 51–60 46 27.1 30 29.1 76 27.8  
 61–70 60 35.3 39 37.8 99 36.2  
 >70 27 15.9 21 20.4 48 17.5  
 Sex        
 M 116 68.2 68 66 184 67.4 0.705 
 F 54 31.7 35 34 89 32.6  
 BMI        
 <25 55 32.3 36 34.9 91 33.3 0.737 
 25–30 89 52.3 49 47.5 138 50.5  
 >30 26 15.3 18 17.4 44 16.1  
 ASA        
 I/II 118 69.4 76 73.8 194 71.1 0.440 
 III/IV 52 30.6 27 26.2 79 28.9  
 Location        
 Inferior rectum<6 cm 89 52.3 33 32 122 44.6 0.002 
 Middlerectum 6–11 cm 54 31.8 39 37.9 93 34.0  
 Superior rectum>11 cm 27 15.9 31 30.1 58 21.2  
 Tumour stage        
 T0 25 14.7 – – 25 9.1 <0.001 
 T1 13 7.6 8 7.9 21 7.8  
 T2 44 25.8 43 41.6 87 31.8  
 T3 80 47.1 42 40.6 122 44.7  
 T4 8 4.8 10 9.9 18 6.6  
 N0 116 68.2 71 68.9 187 69.2 0.449 
 N1 42 24.7 21 20.3 63 23.3  
 N2 12 7.1 11 10.6 23 8.4  
 M0 158 92.9 79 76.7 237 87 0.001 
 M1 12 7 24 23.3 36 13  
 Type of surgery        
 AR 120 70.6 81 78.6 201 73.6 0.308 
 APR 41 24.1 16 15.5 57 20.9  
 Hartmann 9 5.3 6 5.8 15 5.5  
 Mean surgical duration 
(min) 
170  150    0.405 
 range) 70–540  45–
330 
    
 Mean hospital stay (days) 10  10   10 0.287 
 (range) 5–25  3–45   3–45  
 Ileostomy 46 38.3 7 8.6 53 19.4 <0.001 
 Associated surgery 22 12.9 23 22.3 45 16.4 0.045 
 Blood transfusion 28 16.4 17 16.5 45 16.4 0.754 
 Table 2 Complications 
       
 Group A Percent Group B Percent Total Percent p 
Number of patients with 
complications 
39 22.9 33 32.0 72 26.4 0.098 
Wound infection 15 8.2 7 7.8 22 8.1 0.89 
Abdominal abscess 8 4.7 5 4.9 13 4.8 0.955 
Anastomotic leak 5 4.2 3 3.8 8 3.6 0.797 
Haemorrhage 7 3.5 4 3.9 11 3.7 0.88 
Urinary disturbances 12 6.5 5 4.9 17 5.9 0.582 
Postoperative ileus 15 8.9 10 9.7 25 9.2 0.818 
General complications 13 7.1 10 9.6 23 8.1 0.39 
Mortality 1 0.6 1 1 2 0.7 0.719 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4 POSSUM results by groups of therapy 
 Groups Number of 
patients 
with complication 
Observed 
morbidity (%) 
Mean predicted 
morbidity rate by 
POSSUM (%) 
Observed/predicted 
ratio 
Group A (Rt +S),  
N = 170 
39 22.9 32.05 0.71 
Group B (S), N = 103 33 32 29.1 1.09 
 
POSSUM Physiologic and Operative Severity Score for EnUmeration 
of Morbidity and Mortality, Rt Radiotherapy, S Surgery 
 
 
Table 6 POSSUM results according to type of surgery, age, Dukes and ASA 
Interval (N) 
Number of 
patients with 
complications 
Observed 
morbidity (%) 
Mean predicted 
morbidity rate by 
POSSUM (%) 
Observed/ 
predicted ratio 
Type of surgery     
AR (201) 46 23.1 30.3 0.76 
AAP (56) 20 35.7 31.0 1.15 
Hartmann (15) 6 40.0 46.8 0.85 
Duration of surgery     
<180 min (194) 32 19.9 29.2 0.68 
>180 min (79) 35 35.4 34.2 1.03 
Age     
<51 (50) 10 19.9 26.9 0.73 
51–60 (76) 18 28.9 27.2 1.06 
61–70 (99) 29 34.8 32.0 1.08 
>70 (48) 15 16.4 40.5 0.40 
  
 
 
 
 
 
 
 
POSSUM Physiologic and Operative Severity Score for EnUmeration of Morbidity and Mortality 
 
 
 
Table 7 Results according to risk intervals stratification by POSSUM (%) 
 
Interval of 
POSSUM predicted 
risk (%) 
Number of 
patients with 
complications 
Total number of 
patients 
Percentage (%) 
0–25 30 131 22.9 
25–50 28 105 26.6 
50–75 11 31 35.4 
75–100 3 6 50.0 
POSSUM Physiologic and Operative Severity Score for EnUmeration of Morbidity and Mortality 
 
 
Table 8 Studies using POSSUM [38] 
Study Physiological 
Score 
Operative 
Score 
Statistical 
parameter 
Test 
General surgery 
MRSA vs 
20.9 15.6 Unknown P-POSSUM 
nMRSA [39] 17.4 9.2 – – 
Gastrectomy D2 [40] 14–16 18.5–21 Median POSSUM 
Colorectal surgery 
[41, 42] 
20 13.5 Median POSSUM 
Bariatric surgery [43] 13.95 9.4 Mean POSSUM 
Rectal cancer [38] 14.6 18.3 Mean P-POSSUM 
CUN 16.07 13.03 Mean POSSUM,  
P-POSSUM 
CR-POSSUM 
 MRSA methicillin-resistant Staphylococcus aureus.
Dukes     
Dukes A (39) 13 33.3 31.9 1.04 
Dukes B (129) 32 24.8 25.1 0.98 
Dukes C (59) 15 25.4 34.6 0.73 
Dukes D (6) 4 66.6 51.6 1.29 
ASA     
ASA I/II (161) 40 20.6 27.3 0.75 
ASA III/IV (99) 32 40.5 40.9 0.99 
 
